Researchers have found that semaglutide may lower the risk of Alzheimer’s disease in people with type 2 diabetes (T2D). Read More Post navigation Previous Previous post: Slipping Into the Shoes of a Hospice PatientNext Next post: New formation of neurons from stem cell niche disrupted after stroke